LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Performance exceeding expectations cannot withstand valuation pressure, Wall Street big banks downgrade Figma (FIG.US) target price.
NVIDIA Corporation (NVDA.US) is soon to release its Q4 financial report. Oberheimer expects it to exceed market expectations and reaffirms its "outperform" rating.
Amazon.com, Inc. (AMZN.US) surpasses Walmart Inc. (WMT.US) to top the global revenue list.
Performance exceeding expectations cannot withstand valuation pressure, Wall Street big banks downgrade Figma (FIG.US) target price.
NVIDIA Corporation (NVDA.US) is soon to release its Q4 financial report. Oberheimer expects it to exceed market expectations and reaffirms its "outperform" rating.
Amazon.com, Inc. (AMZN.US) surpasses Walmart Inc. (WMT.US) to top the global revenue list.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
